Royal Osteoporosis Society

• Chair of the Board of Trustees 2019 -
• National Clinical Lead for NICE Guideline on Primary Hyperparathyroidism 2017 - 2019
• Trustee of the Royal Osteoporosis Society 2015 - 
• Chair of the Clinical and Scientific Committee of the Royal Osteoporosis Society 2015 - 2019
• Chair of the Royal Osteoporosis Society Conference Organising Committe 2015 - 2019
• Member Clinical and Scientific Committee 2010 -
• Member Vitamin D National Guidelines authoring group 2011 - Published April 2013
• Member National Non-hip Fracture Standards of Care authoring group 2012 - 2016
• Clinical Lead and Chairman for Fracture Liason Service Standards 2014 - 2018
• Clinical Lead and Chief Reviewer - National Peer Review of Osteoporosis Services 2014 - 2018

National Osteoporosis Guidleine Group

• Member of the National Osteoporosis Guideline Group Advisory Board 2015 - 

Society for Endocrinology

• Member of Council for the Society for Endocrinology (SfE) 2003 - 2008
• Convenor of the Bone and Mineral Specialist Interest Group of the SfE 2005 - 2015
• Member Public Engagment Committee of the SfE 2012 - 2016
• Lead for Interdisciplinary Osteoporosis Peer Review 2010 - 2013

British National Formulary

• Endocrinology Adviser to the British National Formulary (BNF) 2000 -

NHS England 

• Member of Clinical Reference Group for the devleopment of national commissioning of specialist endocrinology services  2012 -

• Deputy Chairman of Speciailised Endocrinology Clinical Reference Group - NHS England 2013 - 2019

• Chairman of Specialised Endocrinology CRG, NHSE/NHSI 2019 -

Department of Health and Social Care

• Member of West Midlands Regional Advisory Committee on Clinical Excellence Awards (ACCEA) - 2018 -

• Medical Vice Chair, West Midlands Regional Advisory Committee on Clinical Excellence Awards (ACCEA) - 2018 -

National Institute for Health and Care Excellence

• NICE Guideline NG132 - Clinical Lead for Primary Hyperparathyroidism, 2019
• Rapid Evidence Review - Vitamin D and COVID-19, 2020